Kerala Ayurveda (BOM:530163) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530163 Kerala Ayurveda Ltd BOM:530163
48 GF Score
Price ₹180.95
GF Value ₹352.10
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Kerala Ayurveda Marketable Securities?

Kerala Ayurveda BOM:530163 -2.16% 48 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:530163 with a GF Score™ of 48/100 and a GF Value™ of ₹352.10 (Possible Value Trap). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Kerala Ayurveda's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Kerala Ayurveda's annual Marketable Securities stayed the same from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹23 Mil).

Kerala Ayurveda  (BOM:530163) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Kerala Ayurveda Marketable Securities Related Terms

Kerala Ayurveda Marketable Securities Historical Data

* Premium members only.

The historical data trend for Kerala Ayurveda's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kerala Ayurveda Marketable Securities Chart

Kerala Ayurveda Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 12.17 0.00 0.00 22.91

Kerala Ayurveda Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 9.62 0.00 22.91 0.00
BOM:530163
48GF Score
Kerala Ayurveda Ltd BOM:530163
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kerala Ayurveda Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Kerala Ayurveda (BOM:530163) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Kerala Ayurveda and its competitors.
Is Kerala Ayurveda's Marketable Securities too high?
Kerala Ayurveda's current Marketable Securities is ₹0 Mil. Overall, Kerala Ayurveda has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Marketable Securities compare to ZTS?
Kerala Ayurveda's Marketable Securities of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Kerala Ayurveda and its competitors. Kerala Ayurveda's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹352.10, compared to a current price of ₹180.95 — trading 48.6% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Kerala Ayurveda's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?

Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued. The current stock price of ₹180.95 is trading 48.6% below its estimated GF Value™ of ₹352.10. GuruFocus considers Kerala Ayurveda to be Possible Value Trap.

Key valuation signals for BOM:530163:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹352.10 vs. price of ₹180.95 (48.6% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kerala Ayurveda Business Description

Address XV/551, Athani Post, Nedumbassery, Ernakulam District, Ernakulam, KL, IND, 683585
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
48GF Score

Get the complete analysis for BOM:530163

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹180.95
Price
₹352.10
GF Value